MEDLINE ($MDLN) posted quarterly earnings results for Q2 2026 on Wednesday, August 5th. The company reported earnings of $0.50 per share, beating estimates of $0.33 by $0.17. The company also reported revenue of $7,685,000,000, beating estimates of $7,668,271,912 by $16,728,088.
You can see Quiver Quantitative's $MDLN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDLINE Insider Trading Activity
MEDLINE insiders have traded $MDLN stock on the open market 31 times in the past 6 months. Of those trades, 1 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:
- 8 HOLDINGS MOZART MANAGER L.L.C. BCP has made 0 purchases and 8 sales selling 61,170,810 shares for an estimated $2,345,618,751.
- MOZART ML-2 HOLDCO L.P. BX has made 0 purchases and 8 sales selling 61,170,810 shares for an estimated $2,345,618,751.
- & FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 8 sales selling 57,999,474 shares for an estimated $2,222,909,857.
- GROUP CAYMAN INVESTMENT HOLDINGS, L.P. TC sold 26,105,840 shares for an estimated $1,070,339,440
- GROUP INC. CARLYLE sold 26,105,840 shares for an estimated $1,070,339,440
- MOZART COINVESTMENT HOLDINGS, L.P. CARLYLE sold 26,105,840 shares for an estimated $1,070,339,440
- CIRCLE ML HOLDCO GP, LLC CP sold 26,105,840 shares for an estimated $1,070,339,440
- DOUGLAS P GOLWAS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $3,677,115.
- JESSI L CORCORAN (Principal Accounting Officer) purchased 5,000 shares for an estimated $170,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MEDLINE Hedge Fund Activity
We have seen 271 institutional investors add shares of MEDLINE stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- H&F CORPORATE INVESTORS X, LTD. removed 13,040,572 shares (-13.1%) from their portfolio in Q1 2026, for an estimated $580,305,454
- EGERTON CAPITAL (UK) LLP added 12,105,082 shares (+277.3%) to their portfolio in Q2 2026, for an estimated $477,424,434
- FMR LLC added 10,201,987 shares (+38.7%) to their portfolio in Q1 2026, for an estimated $453,988,421
- CAPITAL RESEARCH GLOBAL INVESTORS added 8,377,467 shares (+56.7%) to their portfolio in Q1 2026, for an estimated $372,797,281
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 8,319,490 shares (+71.9%) to their portfolio in Q2 2026, for an estimated $328,120,685
- SURGOCAP PARTNERS LP added 6,075,165 shares (+inf%) to their portfolio in Q1 2026, for an estimated $270,344,842
- BANQUE PICTET & CIE SA added 5,891,183 shares (+414.6%) to their portfolio in Q2 2026, for an estimated $232,348,257
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MEDLINE Analyst Ratings
Wall Street analysts have issued reports on $MDLN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Tigress Financial issued a "Buy" rating on 05/13/2026
To track analyst ratings and price targets for MEDLINE, check out Quiver Quantitative's $MDLN forecast page.
MEDLINE Price Targets
Multiple analysts have issued price targets for $MDLN recently. We have seen 14 analysts offer price targets for $MDLN in the last 6 months, with a median target of $53.5.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $45.0 on 06/03/2026
- Glen Santangelo from Barclays set a target price of $45.0 on 06/01/2026
- Navann Ty from BNP Paribas set a target price of $40.0 on 05/14/2026
- Ivan Feinseth from Tigress Financial set a target price of $62.0 on 05/13/2026
- David Larsen from BTIG set a target price of $55.0 on 05/07/2026
- Lee Hambright from Bernstein set a target price of $54.0 on 05/07/2026
- Patrick Donnelly from Citigroup set a target price of $55.0 on 05/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
